Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-023385

Chief Executive Officer sold 18,568 shares at an average $54.21 ($1,006,580)

  • Chief Executive Officer acquired 13,250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2025-02-18 Option exercise 10b5-1 +13,250 208,541 D
Kulkarni Samarth Chief Executive Officer 2025-02-18 Sale 10b5-1 −11,640 $55.05 $640,782 196,901 D
Kulkarni Samarth Chief Executive Officer 2025-02-19 Sale 10b5-1 −6,928 $52.80 $365,798 189,973 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2025-02-18 Option exercise · Restricted Stock Units 10b5-1 −13,250 13,250 D
Open-market sales · 18,568 sh · avg $54.21 · $1,006,580
Loading xslF345X05/ownership.xml…